By Ted Bosworth
Vienna—Daily use of aspirin has no effect—good or bad—on outcomes in inflammatory bowel disease, according to a retrospective study undertaken in a registry with 764 patients. The study looked at three key outcome measures, controlled for covariables and length of follow-up, and showed no significant associations.
In contrast to some previous studies that have associated other nonsteroidal anti-inflammatory drugs with IBD flares, “these findings support the